News

Latest valve and structural heart intelligence

19 articles from Diagnostic & Interventional Cardiology
DIC
trial·17 days ago·Diagnostic & Interventional Cardiology

Abbott Begins Enrollment in Global Trial of Investigational Mitral Valve Replacement System

Abbott has initiated enrollment in a global clinical trial evaluating its investigational transcatheter mitral valve replacement system. No specific enrollment targets, trial design details, or timeline information were provided in the article.

Digest: This represents Abbott's strategic entry into the competitive TMVR market, currently dominated by early-stage investigational devices from Edwards and Medtronic.

TMVRAbbottTrialRead original
DIC
industry·17 days ago·Diagnostic & Interventional Cardiology

GE HealthCare Introduces Ceiling-Mounted Image Guiding System

GE HealthCare has launched a ceiling-mounted image guiding system for interventional procedures. No specific clinical performance data or technical specifications were provided in the brief announcement.

Digest: Advanced imaging systems are critical infrastructure for structural heart interventions including TAVR and TMVR, potentially improving procedural visualization and workflow efficiency.

ImagingMarketRead original
DIC
news·18 days ago·Diagnostic & Interventional Cardiology

Elucid Presents Data from ELUCIDATE Study at TCT

Elucid presented data from the ELUCIDATE study at the Transcatheter Cardiovascular Therapeutics (TCT) conference. Specific clinical findings and outcomes from the study were not detailed in the available content.

Digest: ELUCIDATE study findings may provide insights into advanced imaging or plaque characterization technologies relevant to risk stratification in structural heart disease patients.

ImagingTrialRead original
DIC
trial·18 days ago·Diagnostic & Interventional Cardiology

Medtronic Presents Design and Baseline Characteristics of Patients in the Evolut EXPAND TAVR II Trial

Medtronic presented the trial design and baseline patient characteristics from the Evolut EXPAND TAVR II trial. The presentation provides foundational data on the patient population enrolled in this ongoing clinical investigation of the Evolut transcatheter aortic valve platform.

Digest: Understanding baseline characteristics and trial design is essential for interpreting future outcomes data and assessing the applicability of results to real-world TAVR populations.

TAVRMedtronicTrialRead original
DIC
industry·19 days ago·Diagnostic & Interventional Cardiology

GE HealthCare Adds AI-assisted Capabilities for Vscan Air Handheld Ultrasound System

GE HealthCare has added AI-assisted capabilities to its Vscan Air handheld ultrasound system. No specific clinical data or performance metrics were provided in the announcement.

Digest: Enhanced point-of-care ultrasound capabilities may improve bedside structural heart assessment and procedural guidance, though clinical validation data are needed.

ImagingMarketRead original
DIC
trial·19 days ago·Diagnostic & Interventional Cardiology

Abbott Announces 30-day Clinical Trial Results for Coronary Intravascular Lithotripsy System

Abbott announced 30-day results from a clinical trial evaluating its coronary intravascular lithotripsy (IVL) system for treating calcified coronary artery lesions. The trial assessed safety and performance of the device in modifying severely calcified coronary lesions prior to stenting.

Digest: This represents Abbott's entry into the coronary IVL space, a market currently dominated by Shockwave Medical, and could expand treatment options for complex calcified coronary disease that structural heart teams encounter in TAVR and other transcatheter procedures.

AbbottTrialFDARead original
Diagnostic & Interventional Cardiology
regulatory·25 days ago·Diagnostic & Interventional Cardiology

PVL Occluder Receives FDA Clearance

Abbott received FDA approval for the Amplatzer Paraclose PVL Occluder, the first transcatheter device specifically designed to treat paravalvular leak following surgical valve replacement. The approval was supported by the PARADIGM study, a prospective multicenter trial of 200 patients demonstrating effective minimally invasive closure of PVL as an alternative to repeat open-heart surgery.

Digest: This approval addresses a significant unmet need for the 5-17% of surgical valve replacement patients who develop paravalvular leak, providing the first purpose-built transcatheter solution to avoid repeat cardiac surgery.

FDAAbbottSurgicalMinimally InvasiveRead original
Diagnostic & Interventional Cardiology
regulatory·about 1 month ago·Diagnostic & Interventional Cardiology

FDA Approves Transcatheter Tricuspid Valve Repair System

The FDA approved Edwards Lifesciences' PASCAL Precision system for transcatheter edge-to-edge repair (T-TEER) in patients with symptomatic severe tricuspid regurgitation at intermediate or greater surgical risk. Additionally, the FDA approved the PASCAL Ace with Capture Clarity system for degenerative mitral TEER, featuring the first fluoroscopic indicators to confirm leaflet capture.

Digest: Edwards becomes the only company offering both transcatheter repair and replacement therapies for mitral and tricuspid valves in the U.S., expanding treatment options for TR patients and introducing novel fluoroscopic confirmation technology to simplify TEER procedures.

FDATTVRTMVREdwardsRead original
Diagnostic & Interventional Cardiology
regulatory·about 2 months ago·Diagnostic & Interventional Cardiology

FDA Approves Surgical Pulmonary Valve for Pediatric Patients

The FDA approved Edwards Lifesciences' AUTUS Size-Adjustable Valve, the first surgical pulmonary valve designed for pediatric congenital heart disease patients that can be expanded transcatheter as the child grows. The pivotal study met primary endpoints with 100% freedom from device-related complications at 30 days, no reinterventions at 6 months, and at 1 year all patients maintained RVOT mean gradients ≤40 mmHg with less than moderate pulmonary regurgitation.

Digest: This approval addresses a significant unmet need in pediatric congenital heart disease by potentially reducing the number of repeat open-heart surgeries through transcatheter valve expansion, representing a paradigm shift in long-term care planning for this vulnerable population.

FDAEdwardsCongenitalSurgicalRead original
Diagnostic & Interventional Cardiology
research·about 2 months ago·Diagnostic & Interventional Cardiology

Study: Heart Valve Replacement Has Different Risks for Women vs. Men

A study of 1,114 TAVR patients at Karl Landsteiner University identified sex-specific differences in outcomes related to pacemaker implantation following the procedure. Women showed increased vulnerability immediately after new pacemaker implantation post-TAVR, while pre-existing pacemakers in men were associated with long-term risk.

Digest: These findings suggest that sex-specific risk stratification for conduction abnormalities and pacemaker need should be incorporated into pre-procedural TAVR assessment and post-procedural management, particularly as TAVR expands to younger, lower-risk populations.

TAVRLow RiskTrialRead original
Diagnostic & Interventional Cardiology
research·about 2 months ago·Diagnostic & Interventional Cardiology

NIH Awards Grant to Help Improve Mitral Valve Surgery Decisions

Mount Sinai researchers received a $3.6 million, four-year NIH grant to develop EVOLVE-MR, a project linking randomized trial data with Medicare records to extend mitral valve surgery evidence to real-world populations. The study will use machine learning and causal inference methods to determine whether clinical trial benefits persist in broader, more diverse patient groups over longer follow-up periods.

Digest: This research addresses the critical gap between clinical trial populations and real-world mitral regurgitation patients, potentially enabling more individualized surgical decision-making for the 13 million U.S. adults with valvular heart disease.

TrialSurgicalGuidelinesReimbursementRead original
Diagnostic & Interventional Cardiology
news·2 months ago·Diagnostic & Interventional Cardiology

Nicklaus Children's Hospital Performs Transcatheter Fontan Completion on Two-Year-Old Child

Nicklaus Children's Hospital performed one of the first transcatheter Fontan completions in the United States on a 2-year-old child with double-outlet right ventricle, using a catheter-based approach instead of traditional open-heart surgery. The patient recovered well and was discharged home, avoiding additional sternotomy for the final stage of single-ventricle palliation.

Digest: This represents an important expansion of minimally invasive techniques into complex congenital heart disease, potentially establishing a paradigm shift in Fontan completion that could reduce surgical morbidity and recovery time for single-ventricle patients.

CongenitalMinimally InvasiveSurgicalRead original
Diagnostic & Interventional Cardiology
industry·3 months ago·Diagnostic & Interventional Cardiology

Ventripoint Expands Subscription Access to AI Cardiac Imaging

Ventripoint Diagnostics is expanding subscription-based access to its FDA-cleared VMS+ 4.0 platform, which uses AI and Knowledge Based Reconstruction technology to generate MRI-comparable 3D volumetric measurements of all four cardiac chambers from standard echocardiographic images. The company is implementing a Device-as-a-Service model targeting approximately 80% subscription-based adoption to reduce capital budget barriers for hospital implementation.

Digest: This AI-powered echocardiographic platform addresses a critical need for accurate right ventricular volumetric assessment without requiring MRI, with subscription pricing potentially lowering adoption barriers for structural heart programs evaluating patients for interventions.

ImagingFDAMarketRead original
Diagnostic & Interventional Cardiology
industry·3 months ago·Diagnostic & Interventional Cardiology

ASCEND Cardiovascular, Epsilon Imaging Partner to Streamline Adult and Pediatric Advanced Echo Analysis

ASCEND Cardiovascular and Epsilon Imaging announced a strategic partnership integrating ASCEND's enterprise structured reporting platform with Epsilon's EchoInsight Zero Footprint advanced echo analysis system featuring speckle-tracking strain imaging. The integrated solution uses AI-based view classification and bidirectional data exchange to automate strain measurement workflow, generating over 100 standardized measurements based on ASE chamber quantification guidelines without manual data entry.

Digest: Automated strain imaging integration addresses a key workflow barrier to routine use of global longitudinal strain for cardiotoxicity monitoring, heart failure assessment, and valvular disease management in structural heart programs.

ImagingMarketRead original
Diagnostic & Interventional Cardiology
trial·4 months ago·Diagnostic & Interventional Cardiology

Clinical Study to Look at Real-World Use of Transcatheter Edge-to-Edge Repair System for Leaky Tricuspid Heart Valve

Abbott has initiated the Treat TR study, a post-market study enrolling approximately 1,000 patients across up to 100 sites in the U.S., Canada, and Europe to evaluate the safety and performance of the TriClip transcatheter edge-to-edge repair system for tricuspid regurgitation in real-world settings. Patients will be followed for five years, with a sub-study examining the system's potential to reverse cardiac remodeling.

Digest: This large-scale real-world evidence study will provide critical post-market performance data for TriClip TEER, informing adoption decisions and potentially expanding treatment paradigms for TR in clinical practice.

TTVRAbbottTrialMinimally InvasiveRead original
Diagnostic & Interventional Cardiology
industry·4 months ago·Diagnostic & Interventional Cardiology

HOPPR Introduces New AI Model for Chest CT Exams

HOPPR launched its fifth AI foundation model, the EF Chest CT Narrative Model, which processes 3D chest CT volumes to generate narrative reports across pulmonary, mediastinal, cardiac, upper abdominal, osseous, and soft tissue regions. The model was trained on a large proprietary U.S. dataset with deliberate overrepresentation of serious conditions including aortic injury, pulmonary embolism, rib fractures, and pneumothorax.

Digest: This AI model offers potential automated assessment of cardiac and aortic anatomy on chest CT, which could support preprocedural planning and screening for structural heart interventions, though clinical validation data were not provided.

ImagingFDARead original
Diagnostic & Interventional Cardiology
regulatory·4 months ago·Diagnostic & Interventional Cardiology

ElectroWire Medical Gets FDA Nod for LightningWire Transseptal Puncture System

ElectroWire Medical received FDA 510(k) clearance for the LightningWire Transseptal Puncture System, a novel electrosurgical guidewire designed to create atrial septal defects for left-sided cardiac procedures. The 0.032-inch diameter system features proprietary insulation enabling low-power transseptal puncture while providing stiffness comparable to 0.035-inch guidewires, with compatibility across existing electrosurgical generators and transseptal introducers.

Digest: This device addresses a critical access step for multiple structural heart procedures including TMVR, LAAO, and atrial fibrillation ablation, potentially improving procedural efficiency and reducing costs through platform-agnostic compatibility.

FDATMVRMinimally InvasiveMarketRead original
Diagnostic & Interventional Cardiology
research·5 months ago·Diagnostic & Interventional Cardiology

Researchers Develop Clinical Tool to Help Diagnose Pulmonary Hypertension

University of Maryland researchers developed an AI-powered clinical support tool that analyzes electronic health records to identify undiagnosed pulmonary hypertension by automatically extracting and predicting missing mean pulmonary artery pressure measurements from right heart catheterization reports. The system was tested on 17,292 catheterization reports from over 11,000 patients treated between 2016-2024, addressing the clinical challenge that mPAP is missing in 7-33% of cases depending on the dataset.

Digest: This tool addresses a diagnostic gap in pulmonary hypertension detection that affects appropriate patient selection and hemodynamic assessment for structural heart interventions, particularly in evaluating patients for tricuspid and mitral valve procedures where pulmonary pressures are critical eligibility criteria.

TTVRTMVRImagingHigh RiskRead original
Diagnostic & Interventional Cardiology
news·about 7 years ago·Diagnostic & Interventional Cardiology

Highlighting Innovation at the University of Colorado Hospital Cardiology Program

University of Colorado Hospital's Heart and Vascular Center performs approximately 3,000 interventional and structural heart procedures annually, including complex PCI with hemodynamic support and transcatheter mitral valve repair. The program has participated in pivotal trials for structural heart devices and performs 25-50 chronic total occlusion procedures and 50 Impella-supported high-risk PCI cases per year.

Digest: This academic center's experience with MitraClip procedures, complex high-risk PCI, and participation in pivotal device trials provides insights into advanced structural heart program development and procedural volumes at high-performing institutions.

TMVRAbbottHigh RiskImagingRead original